MR
Moderna
MRNA · NASDAQ
$145.55 -4.87% (-$7.45)
1M +170.24%
Market Cap $59.1B
P/E Ratio -
Div. Yield -
ROE 39.21%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 26.51x
P/B 8.74x
P/E N/A
Growth
0 /100
Declining Rev. growth 53.13%
Book val. growth 23.24%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 12.57%
FCF margin 54.89%
Net margin 141.43%
Quality
3 /100
Poor ROIC 39.97%
Asset turnover 0.20x
ROE 39.21%
Debt
69 /100
Low Debt/Equity 0.19x
Int. coverage -122.80x
Current ratio 2.29x
Stability
50 /100
Moderate Beta 0.90x
Profitable years 0
Rev. volatility 12.29%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MRNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stéphane Bancel
Employees
4,700
Headquarters
Cambridge
Nadcházející události
05 LIS
Earnings
Upcoming earnings report